Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Conditional Cash Transfers to Increase Retention in PMTCT Services in Akwa Ibom State, Nigeria

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02447159
Recruitment Status : Completed
First Posted : May 18, 2015
Last Update Posted : May 3, 2017
Sponsor:
Collaborators:
University of California, Berkeley
New Incentives
Bill and Melinda Gates Foundation
Information provided by (Responsible Party):
Jenny Liu, PhD, MPP, University of California, San Francisco

Brief Summary:
A randomized controlled trial will be conducted to assess the effectiveness of conditional cash transfers (CCTs) at increasing retention in prevention of mother-to-child transmission (PMTCT) services specifically, in relation to pickup of ARV drugs for infected mothers, delivery in the hospital setting, and receipt of drugs for exposed infants. Administrative data will be extracted from the All Babies are Equal program and hospital records. At 8-10 weeks after delivery, an endline survey will also be conducted with each participant to provide a deeper understanding of the impact of the CCTs and to assess the reasons for retention in PMTCT services.

Condition or disease Intervention/treatment Phase
HIV HIV Infections Pregnancy Infant, Newborn, Diseases Behavioral: Conditional Cash Transfers Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 554 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Evaluation of Conditional Cash Transfers to Increase Retention in PMTCT Services in Akwa Ibom State, Nigeria
Actual Study Start Date : August 2015
Actual Primary Completion Date : March 2017
Actual Study Completion Date : April 2017

Arm Intervention/treatment
Experimental: Intervention
Each participant in the intervention arm will receive conditional cash transfers when she: (1) registers pregnancy, (2)picks up her medication in the first two months after her first visit, (3) delivers at the health clinic, and (4) receives early infant diagnosis test for newborn. Eight to ten weeks after delivery, the participant will also be asked to participate in an endline survey and will be compensated for her time.
Behavioral: Conditional Cash Transfers
Each participant in the intervention arm will receive conditional cash transfers when she: (1) registers pregnancy, (2)picks up her medication in the first two months after her first visit, (3) delivers at the health clinic, and (4) receives early infant diagnosis test for newborn. Eight to ten weeks after delivery, the participant will also be asked to participate in an endline survey and will be compensated for her time.

No Intervention: Control
Antenatal care utilization data will be extracted from the administrative records. Eight to ten weeks after delivery, the participant will also be asked to participate in an endline survey and will be compensated for her time.



Primary Outcome Measures :
  1. Number and percentage of pregnant women who deliver their baby at the facility in which they were first enrolled for antenatal care [ Time Frame: When the woman delivers her child ]
  2. Number and percentage of mothers who obtain early infant diagnosis testing 6-8 weeks after giving birth to their child [ Time Frame: 6-8 weeks after the woman delivers her child ]

Secondary Outcome Measures :
  1. Number and percentage of pregnant women who pick up their antiretroviral treatment drugs at least once between enrolling in antenatal care and giving birth to their baby at the facility where they first enrolled in antenatal care [ Time Frame: Between enrollment into antenatal care until the woman delivers her child ]
  2. Number and percentage of mothers who pick up Nevirapine for their newborn infant at the facility where they first enrolled in antenatal care after giving birth [ Time Frame: 48 hours after the woman delivers her child ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   15 Years to 45 Years   (Child, Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • HIV positive
  • Pregnant
  • Attended an antenatal care visit at one of three participating clinics.

Exclusion Criteria:

  • Not HIV positive
  • Not pregnant
  • Not registered for antenatal care at a participating clinic.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02447159


Locations
Layout table for location information
Nigeria
Immanuel General Hospital
Eket, Akwa Ibom, Nigeria
General Hospital, Ikot Ekpene
Ikot Ekpene, Akwa Ibom, Nigeria
General Hospital, Iquita Oron
Oron, Akwa Ibom, Nigeria
Sponsors and Collaborators
University of California, San Francisco
University of California, Berkeley
New Incentives
Bill and Melinda Gates Foundation
Investigators
Layout table for investigator information
Principal Investigator: Jenny Liu, PhD, MPP University of California, San Francisco
Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Jenny Liu, PhD, MPP, Economist, University of California, San Francisco
ClinicalTrials.gov Identifier: NCT02447159    
Other Study ID Numbers: CCT for PMTCT
First Posted: May 18, 2015    Key Record Dates
Last Update Posted: May 3, 2017
Last Verified: May 2017
Keywords provided by Jenny Liu, PhD, MPP, University of California, San Francisco:
Nigeria
Developing Countries
Hospitals, Maternity/Utilization
Hospitals/Economics
HIV
Additional relevant MeSH terms:
Layout table for MeSH terms
Infant, Newborn, Diseases